Pillstats
Rx only · Injection, Solution, Concentrate · Intravenous

Sodium Acetate

Sodium Acetate Anhydrous

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCB05XA08
RxCUI (US)56443
US makers4 labelers
Packages11
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.6K7.2K11K14K2025 Q12025 Q22025 Q32025 Q42026 Q1
12K
Rx · 2026 Q1
2.3M
Units dispensed
+77%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Hospira, Inc.unknown6SUPPLYING
MILLA PHARMACEUTICALS INC.unknown2SUPPLYING
Amneal Pharmaceuticals Private Limitedunknown2SUPPLYING
Fresenius Kabi USA, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 4, 2022
    RECALLRecall (Class I): Sodium Acetate Injection, USP, 400 mEq / 100 mL (4 mEq / mL), packaged in 2 trays of 20 vials per shipper (NDC 63323-03…

    Presence of particulate matter: particulates composed of carbon and oxygen with varying amounts of iron and trace amounts of sodium, silicon, chromium, aluminum and cellulose. — Recalling firm: Fresenius Kabi USA, LLC — Nationwide USA

  • Mar 23, 2016
    SHORTAGEDrug shortage: Sodium Acetate Injection (Fresenius Kabi USA, LLC)

    Sodium Acetate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Total Parenteral Nutrition.

  • Feb 3, 2016
    SHORTAGEDrug shortage: Sodium Acetate Injection (Milla Pharmaceuticals)

    Sodium Acetate Injection — reported in shortage by Milla Pharmaceuticals. Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Pediatric, Total Parenteral Nutrition.

  • Feb 3, 2016
    SHORTAGEDrug shortage: Sodium Acetate Injection (Hospira, Inc., a Pfizer Company)

    Sodium Acetate Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Pediatric, Total Parenteral Nutrition.

  • Feb 26, 2013
    RECALLRecall (Class II): Sodium Acetate Injection, USP, 40 mEq/20 ml (2 mEq/mL) 20 mL Single-Dose Fliptop, Rx only, HOSPIRA, INC. LAKE FOREST, I…

    Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. — Recalling firm: Hospira Inc. — Nationwide and Puerto Rico